Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance ; volume:35 ; number:11 ; day:25 ; month:9 ; year:2018 ; pages:2041-2053 ; date:11.2018
Advances in therapy ; 35, Heft 11 (25.9.2018), 2041-2053, 11.2018
- Creator
-
Sabidó, Meritxell
Venkatesh, Saritha
Hayward, Brooke
Aldridge, Julie
Gillett, Alan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-018-0790-1
- URN
-
urn:nbn:de:101:1-2018122700191711976694
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sabidó, Meritxell
- Venkatesh, Saritha
- Hayward, Brooke
- Aldridge, Julie
- Gillett, Alan
- SpringerLink (Online service)
Other Objects (12)
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records